Literature DB >> 8094006

Cervical carcinoma: low frequency of allele loss at loci implicated in other common malignancies.

R M Busby-Earle1, C M Steel, C C Bird.   

Abstract

Twenty cervical carcinomas were examined for loss of heterozygosity (LOH) using 22 RFLP markers, which mapped to regions of putative oncosuppressor gene loci, identified as candidates in other common solid tumours. Allele losses were identified in six of the eight chromosomal arms examined, but at a significantly lower frequency than that reported in other common solid tumours. No association was observed between allele losses at any chromosomal location and the presence or integration of 'high risk' types of HPV determined by a sensitive, specific PCR method. HPV 16, 18 or 33 were found in the majority (75%) of these tumours. We have looked at only a limited subset of chromosomal regions, but the results, so far, imply that carcinoma of the cervix may arise by different molecular events than other common solid tumours, and support the view that one of the distinctive events may be infection with HPV. Alternatively, similar molecular events may be occurring, but in regions of the genome not yet identified as targets in other solid tumours.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094006      PMCID: PMC1968220          DOI: 10.1038/bjc.1993.11

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

1.  Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer.

Authors:  S L Naylor; B E Johnson; J D Minna; A Y Sakaguchi
Journal:  Nature       Date:  1987 Oct 1-7       Impact factor: 49.962

2.  HPV in full thickness cervical biopsies: high prevalence in CIN 2 and CIN 3 detected by a sensitive PCR method.

Authors:  M J Arends; Y K Donaldson; E Duvall; A H Wyllie; C C Bird
Journal:  J Pathol       Date:  1991-12       Impact factor: 7.996

3.  Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma.

Authors:  J Toguchida; K Ishizaki; M S Sasaki; M Ikenaga; M Sugimoto; Y Kotoura; T Yamamuro
Journal:  Cancer Res       Date:  1988-07-15       Impact factor: 12.701

4.  Chromosome 1 in 26 carcinomas of the cervix uteri: structural and numerical changes.

Authors:  N B Atkin; M C Baker
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

5.  Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomas.

Authors:  M Kaelbling; R D Burk; N B Atkin; A B Johnson; H P Klinger
Journal:  Lancet       Date:  1992-07-18       Impact factor: 79.321

6.  Nonrandom chromosome changes in carcinoma of the cervix uteri. I. Nine near-diploid tumors.

Authors:  N B Atkin; M C Baker
Journal:  Cancer Genet Cytogenet       Date:  1982-11

7.  Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma.

Authors:  B Zbar; H Brauch; C Talmadge; M Linehan
Journal:  Nature       Date:  1987 Jun 25-Jul 1       Impact factor: 49.962

8.  Nonrandom chromosome changes in carcinoma of the cervix uteri. II. Ten tumors in the triploid-tetraploid range.

Authors:  N B Atkin; M C Baker
Journal:  Cancer Genet Cytogenet       Date:  1984-11

9.  Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells.

Authors:  P J Saxon; E S Srivatsan; E J Stanbridge
Journal:  EMBO J       Date:  1986-12-20       Impact factor: 11.598

10.  Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma.

Authors:  D M Eccles; L Brett; A Lessells; L Gruber; D Lane; C M Steel; R C Leonard
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

View more
  7 in total

1.  Allelic loss in human papillomavirus-positive and -negative vulvar squamous cell carcinomas.

Authors:  A P Pinto; M C Lin; G L Mutter; D Sun; L L Villa; C P Crum
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

2.  Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24.

Authors:  G M Hampton; L A Penny; R N Baergen; A Larson; C Brewer; S Liao; R M Busby-Earle; A W Williams; C M Steel; C C Bird
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

Review 3.  Molecular events in uterine cervical cancer.

Authors:  S A Southern; C S Herrington
Journal:  Sex Transm Infect       Date:  1998-04       Impact factor: 3.519

4.  Tumour cells of extramammary Paget's disease do not show either p53 mutation or allelic loss at several selected loci implicated in other cancers.

Authors:  M Takata; N Hatta; K Takehara
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Low frequency of allelic loss in skin tumours from immunosuppressed individuals.

Authors:  I Rehman; A G Quinn; M Takata; A E Taylor; J L Rees
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  p53 mutations in cervical carcinogenesis--low frequency and lack of correlation with human papillomavirus status.

Authors:  R M Busby-Earle; C M Steel; A R Williams; B Cohen; C C Bird
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

7.  Accumulation of p53 is associated with tumour progression in cutaneous lesions of renal allograft recipients.

Authors:  L A Stark; M J Arends; K M McLaren; E C Benton; H Shahidullah; J A Hunter; C C Bird
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.